Previous close | 2.8000 |
Open | 2.8000 |
Bid | 1.3000 |
Ask | 3.2000 |
Strike | 26.00 |
Expiry date | 2023-02-17 |
Day's range | 2.8000 - 2.8000 |
Contract range | N/A |
Volume | |
Open interest | 5 |
In this article we are going to estimate the intrinsic value of Corcept Therapeutics Incorporated ( NASDAQ:CORT ) by...
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for revenues remains a headwind.
Durect (DRRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.